{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:48:38Z","timestamp":1789454918310,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejso.2014.05.007","type":"journal-article","created":{"date-parts":[[2014,6,3]],"date-time":"2014-06-03T00:48:46Z","timestamp":1401756526000},"page":"1237-1244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: A comparative study in 363 patients"],"prefix":"10.1016","volume":"40","author":[{"given":"C.","family":"Ng\u00f4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Brugier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Plancher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"de la Rochefordi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Alran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"F\u00e9ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Malhaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rouzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Fourchotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9114","key":"10.1016\/j.ejso.2014.05.007_bib1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group","volume":"351","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejso.2014.05.007_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/gyno.2000.5859","article-title":"Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer","volume":"78","author":"Deligdisch","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2014.05.007_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2004.03.048","article-title":"Endometrial pathologies associated with postmenopausal tamoxifen treatment","volume":"94","author":"Cohen","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2014.05.007_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/(SICI)1097-0215(19980504)76:3<325::AID-IJC7>3.0.CO;2-X","article-title":"Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC)","volume":"76","author":"Mignotte","year":"1998","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2014.05.007_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1006126411210","article-title":"Association between endometrial cancer and tamoxifen treatment of breast cancer","volume":"54","author":"Peters-Engl","year":"1999","journal-title":"Breast Cancer Res Treat"},{"issue":"9233","key":"10.1016\/j.ejso.2014.05.007_bib6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","article-title":"Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen","volume":"356","author":"Bergman","year":"2000","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ejso.2014.05.007_bib7","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/oxfordjournals.annonc.a010406","article-title":"Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan","volume":"11","author":"Matsuyama","year":"2000","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2014.05.007_bib8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/jnci\/dji057","article-title":"British Tamoxifen Second Cancer Study Group. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study","volume":"97","author":"Swerdlow","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"22","key":"10.1016\/j.ejso.2014.05.007_bib9","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"25","key":"10.1016\/j.ejso.2014.05.007_bib10","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1200\/JCO.2007.14.0921","article-title":"Impact of raloxifene or tamoxifen use on endometrial cancer risk: a population-based case-control study","volume":"26","author":"DeMichele","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2014.05.007_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2014.05.007_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","article-title":"Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14","volume":"86","author":"Fisher","year":"1994","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ejso.2014.05.007_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1993.11.3.485","article-title":"High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients","volume":"11","author":"Magriples","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2014.05.007_bib14","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2002.20.11.2758","article-title":"Association of tamoxifen and uterine sarcoma","volume":"20","author":"Wickerham","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.ejso.2014.05.007_bib15","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM200206063462319","article-title":"Uterine sarcoma associated with tamoxifen use","volume":"346","author":"Wysowski","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2014.05.007_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1525-1438.2002.01134.x","article-title":"Tamoxifen-related uterine carcinosarcomas occur under\/after prolonged treatment: report of five cases and review of the literature","volume":"12","author":"Kloos","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejso.2014.05.007_bib17","series-title":"Incidence et mortalit\u00e9 des cancers en France","author":"Institut de veille sanitaire, H.d.L., r\u00e9seau fran\u00e7ais des registres de cancer, Institut National du Cancer","year":"2011"},{"issue":"2","key":"10.1016\/j.ejso.2014.05.007_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygyno.2012.07.105","article-title":"Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure","volume":"127","author":"Tergas","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2014.05.007_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-007-9823-1","article-title":"Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer","volume":"112","author":"Hoogendoorn","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.ejso.2014.05.007_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1048-891x.2004.14313.x","article-title":"Uterine serous carcinoma: a comparison of therapy for advanced-stage disease","volume":"14","author":"Gehrig","year":"2004","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2014.05.007_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.AOG.0000131620.67911.03","article-title":"Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?","volume":"104","author":"Slomovitz","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejso.2014.05.007_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/jnci\/djh007","article-title":"Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer","volume":"96","author":"Curtis","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.ejso.2014.05.007_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ygyno.2008.08.035","article-title":"Relationship between tamoxifen use and high risk endometrial cancer histologic types","volume":"112","author":"Bland","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2014.05.007_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cncr.22734","article-title":"Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen","volume":"110","author":"Saadat","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2014.05.007_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/01443610400024740","article-title":"Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer","volume":"25","author":"Rieck","year":"2005","journal-title":"J\u00a0Obstet Gynaecol"},{"issue":"21","key":"10.1016\/j.ejso.2014.05.007_bib26","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1200\/JCO.2002.99.174","article-title":"Increased risk of malignant mullerian tumor of the uterus among women with breast cancer treated by tamoxifen","volume":"20","author":"Bouchardy","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"9869","key":"10.1016\/j.ejso.2014.05.007_bib27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejso.2014.05.007_bib28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10549-013-2629-4","article-title":"Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials","volume":"140","author":"Petrelli","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2014.05.007_bib29","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1186\/bcr3206","article-title":"Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries","volume":"14","author":"Jones","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejso.2014.05.007_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.rpor.2013.06.005","article-title":"Tamoxifen in breast cancer ipse dixit in uterine malignant mixed M\u00fcllerian tumor and sarcoma \u2013 a report of 8 cases and review of the literature","volume":"18","author":"Cardoso Vasconcelos","year":"2013","journal-title":"Rep Pract Oncol Radiother"},{"issue":"3","key":"10.1016\/j.ejso.2014.05.007_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00428-003-0947-3","article-title":"Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification","volume":"444","author":"Lax","year":"2004","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.ejso.2014.05.007_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/hupa.2001.25929","article-title":"Molecular pathology of endometrial hyperplasia and carcinoma","volume":"32","author":"Matias-Guiu","year":"2001","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.ejso.2014.05.007_bib33","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ejso.2014.05.007_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ijc.21862","article-title":"The relationship between microsatellite instability and PTEN gene mutations in endometrial cancer","volume":"119","author":"Bilbao","year":"2006","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2014.05.007_bib35","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1200\/JCO.2005.04.1574","article-title":"Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma","volume":"24","author":"Black","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2014.05.007_bib36","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.0.CO;2-U","article-title":"The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways","volume":"88","author":"Lax","year":"2000","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2014.05.007_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ygyno.2003.10.040","article-title":"Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study","volume":"92","author":"Wilder","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2014.05.007_bib38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/gcc.20781","article-title":"Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure","volume":"49","author":"Fles","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"issue":"20","key":"10.1016\/j.ejso.2014.05.007_bib39","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1200\/JCO.2000.18.20.3464","article-title":"Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound","volume":"18","author":"Gerber","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2014.05.007_bib40","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1200\/JCO.2000.18.20.3459","article-title":"Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy","volume":"18","author":"Barakat","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2014.05.007_bib41","first-page":"35","article-title":"Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers","volume":"2","author":"Gibson","year":"1996","journal-title":"Cancer J Sci Am"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798314004648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798314004648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T06:31:02Z","timestamp":1565505062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798314004648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0748798314004648"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2014.05.007","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: A comparative study in 363 patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2014.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}